25 May 2013
Keywords: xoma, licenses, bpi, zephyr, sciences, entered, into
Article | 22 November 2004
Xoma has entered into an exclusive worldwide licensing accord with fellow US firm Zephyr Sciences for the research, development and
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.
22 November 2004
24 May 2013
© 2013 thepharmaletter.com